Business · 09/02/2023Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting for Influenza Vaccine Selection
Summary
The FDA is hosting a public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee to discuss and recommend the selection of influenza virus strains for the 2023-2024 season, with public comments invited.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →